Comparison between Sudarshan Pharma Industries IPO and Vertexplus Technologies IPO.
Sudarshan Pharma Industries IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Vertexplus Technologies IPO is a SME Bookbuilding proposed to list at NSE SME.
| Sudarshan Pharma Industries IPO | Vertexplus Technologies IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Gretex Corporate Services Ltd. | Beeline Capital Advisors Pvt.Ltd. |
| Registrar | Kfin Technologies Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Gretex Share Broking Pvt.Ltd. | Prabhat Financial Services Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Sudarshan Pharma Industries IPO is up to ₹47.58 Cr whereas the issue size of the Vertexplus Technologies IPO is up to ₹13.49 Cr. The final issue price of Sudarshan Pharma Industries IPO is ₹73.00 per share and of Vertexplus Technologies IPO is ₹96.00 per share.
| Sudarshan Pharma Industries IPO | Vertexplus Technologies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹71.00 per share | ₹91.00 per share |
| Issue Price (Upper) | ₹73.00 per share | ₹96.00 per share |
| Issue Price (Final) | ₹73.00 per share | ₹96.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 1200 shares |
| Fresh Issue Size | 65,18,400 shares | 14,05,200 shares |
| Fresh Issue Size (Amount) | up to ₹47.58 Cr | up to ₹13.49 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 65,18,400 shares | 14,05,200 shares |
| Issue Size Total (Amount) | up to ₹47.58 Cr | up to ₹13.49 Cr |
Sudarshan Pharma Industries IPO opens on Mar 09, 2023, while Vertexplus Technologies IPO opens on Mar 02, 2023. The closing date of Sudarshan Pharma Industries IPO and Vertexplus Technologies IPO is Mar 14, 2023, and Mar 06, 2023, respectively.
| Sudarshan Pharma Industries IPO | Vertexplus Technologies IPO | |
|---|---|---|
| Anchor Bid Date | Mar 08, 2023 | Mar 01, 2023 |
| Issue Open | Mar 09, 2023 | Mar 02, 2023 |
| Issue Close | Mar 14, 2023 | Mar 06, 2023 |
| Basis Of Allotment (Tentative) | Mar 17, 2023 | Mar 10, 2023 |
| Initiation of Refunds (Tentative) | Mar 20, 2023 | Mar 13, 2023 |
| Credit of Share (Tentative) | Mar 21, 2023 | Mar 14, 2023 |
| Listing date (Tentative) | Mar 22, 2023 | Mar 15, 2023 |
| Anchor Lockin End date 1 | Apr 16, 2023 | Apr 09, 2023 |
| Anchor Lockin End date 2 | Jun 15, 2023 | Jun 08, 2023 |
Sudarshan Pharma Industries IPO P/E ratio is 24.33, as compared to Vertexplus Technologies IPO P/E ratio of 28.83.
| Sudarshan Pharma Industries IPO | Vertexplus Technologies IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials |
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 80.28 | 100.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 24.33 | 28.83 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹175.68 Cr. | ₹52.60 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Sudarshan Pharma Industries IPO Retail Individual Investors (RII) are offered 36,51,200 shares while in Vertexplus Technologies IPO retail investors are offered 36,51,200 shares. Qualified Institutional Buyers (QIB) are offered 5,21,600 shares in Sudarshan Pharma Industries IPO and 2,86,800 shares in Vertexplus Technologies IPO.
| Sudarshan Pharma Industries IPO | Vertexplus Technologies IPO | |
|---|---|---|
| Anchor Investor Reserveration | 7,80,800 shares | 4,15,200 shares |
| Market Maker Reserveration | 3,44,000 shares | 74,400 shares |
| QIB | 5,21,600 shares | 2,86,800 shares |
| NII | 15,64,800 shares | 2,11,200 shares |
| RII | 36,51,200 shares | 4,92,000 shares |
| Employee | ||
| Others | ||
| Total | 65,18,400 shares | 14,05,200 shares |
Sudarshan Pharma Industries IPO subscribed 1.06x in total, whereas Vertexplus Technologies IPO subscribed 11.01x.
| Sudarshan Pharma Industries IPO | Vertexplus Technologies IPO | |
|---|---|---|
| QIB (times) | 1.01x | 1.43x |
| NII (times) | 0.81x | 35.15x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.20x | 15.53x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.06x | 11.01x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
